AKT1 and lung carcinoma: Activation of HER2 induces the phosphorylation of tyrosine residues, leading to the activation of downstream signaling pathways such as MEK/ERK and PI3K/AKT, which in turn increases the migration and proliferation of lung cancer cells (25).